Foundation Awards $1.9 Million for Development of Non-Invasive Neuroimaging Techniques
Investigators could more accurately identify individuals with Parkinson's as well as better characterize disease pathology and relate it to clinical measures of onset and progression. There is also growing interest in therapeutics that directly target alpha-synuclein; hence, a non-invasive imaging tool would be a useful therapeutic response marker for drug makers wishing to test biological impact of potentially disease-modifying drugs. Such tools would have a huge impact on clinical trial designs, allowing for more accurate patient selection and clearer trial outcome measures, the foundation says.
This program was funded with a lead gift from The Edmond J. Safra Foundation, which has been one of the most steadfast supporters of The Michael J. Fox Foundation since its inception, the Fox foundation says.
The Fox foundation says that as with all of its grants, full funding is dependent on the achievement of predetermined, specific milestones and on researchers' agreement to make the results of their work available to the Parkinson's research community.
Watch more breaking news now on our video feed:
Bookmark http://universeeverything.blogspot.com/ and drop back in sometime.